Search research articles
Contact Us
Filters
Showing results (291-300 of 570) with videos related to
Page
of 57
Sort By:
ACS Chemical Neuroscience
|
January 13, 2015
A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances
Michael T Nedelcovych, Robert W Gould, Xiaoyan Zhan, et al.
ACS Chemical Neuroscience
|
January 14, 2026
Discovery of VU6083859, a TAOK1 Selective Inhibitor, and VU6080195, a <i>pan</i>-TAOK Activator
Daniel C Schultz, Lauren C Parr, Hunter Sweet, et al.
ACS Medicinal Chemistry Letters
|
February 14, 2024
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists
Navoda Jayakodiarachchi, Mallory A Maurer, Daniel C Schultz, et al.
ACS Chemical Neuroscience
|
December 2, 2021
Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors
Jeanette L Bertron, Matthew T Duvernay, Sidnee G Mitchell, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 30, 2010
Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)
Darren W Engers, Patrick R Gentry, Richard Williams, et al.
Molecular Pharmacology
|
February 1, 2024
Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B K<sub>ATP</sub> Channels
Kangjun Li, Samantha J McClenahan, Changho Han, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2011
Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold
Richard Williams, Jason T Manka, Alice L Rodriguez, et al.
Journal of Medicinal Chemistry
|
May 31, 2013
Discovery of (R)-(2-fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-hydroxypiperidin-1-yl)methanone (ML337), an mGlu3 selective and CNS penetrant negative allosteric modulator (NAM)
Cody J Wenthur, Ryan Morrison, Andrew S Felts, et al.
Journal of Receptor and Signal Transduction Research
|
November 22, 2024
The cannabinoid CB<sub>2</sub> receptor positive allosteric modulator EC21a exhibits complicated pharmacology <i>in vitro</i>
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2011
Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway
Jimmy R Theriault, Andrew S Felts, Brittney S Bates, et al.
Page
of 57
Search research articles
Search
Showing results (291-300 of 570) with videos related to
Sort By:
Page
of 57
ACS Chemical Neuroscience
|
January 13, 2015
A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances
Michael T Nedelcovych, Robert W Gould, Xiaoyan Zhan, et al.
ACS Chemical Neuroscience
|
January 14, 2026
Discovery of VU6083859, a TAOK1 Selective Inhibitor, and VU6080195, a <i>pan</i>-TAOK Activator
Daniel C Schultz, Lauren C Parr, Hunter Sweet, et al.
ACS Medicinal Chemistry Letters
|
February 14, 2024
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists
Navoda Jayakodiarachchi, Mallory A Maurer, Daniel C Schultz, et al.
ACS Chemical Neuroscience
|
December 2, 2021
Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors
Jeanette L Bertron, Matthew T Duvernay, Sidnee G Mitchell, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 30, 2010
Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)
Darren W Engers, Patrick R Gentry, Richard Williams, et al.
Molecular Pharmacology
|
February 1, 2024
Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B K<sub>ATP</sub> Channels
Kangjun Li, Samantha J McClenahan, Changho Han, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2011
Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold
Richard Williams, Jason T Manka, Alice L Rodriguez, et al.
Journal of Medicinal Chemistry
|
May 31, 2013
Discovery of (R)-(2-fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-hydroxypiperidin-1-yl)methanone (ML337), an mGlu3 selective and CNS penetrant negative allosteric modulator (NAM)
Cody J Wenthur, Ryan Morrison, Andrew S Felts, et al.
Journal of Receptor and Signal Transduction Research
|
November 22, 2024
The cannabinoid CB<sub>2</sub> receptor positive allosteric modulator EC21a exhibits complicated pharmacology <i>in vitro</i>
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2011
Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway
Jimmy R Theriault, Andrew S Felts, Brittney S Bates, et al.
Page
of 57